HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$0.96
Day range
$0.92 - $0.99
Year range
$0.84 - $1.74
Market cap
42.57M USD
Avg Volume
84.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.84M | -7.53% |
Net income | -8.89M | -60.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.54M | 11.76% |
Effective tax rate | -0.58% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.06M | -16.77% |
Total assets | 167.90M | 61.58% |
Total liabilities | 82.82M | 2,396.71% |
Total equity | 85.08M | — |
Shares outstanding | 43.22M | — |
Price to book | 0.48 | — |
Return on assets | -11.53% | — |
Return on capital | -16.04% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.89M | -60.72% |
Cash from operations | -6.08M | -4.16% |
Cash from investing | 5.39M | -71.12% |
Cash from financing | 57.00K | 416.67% |
Net change in cash | -880.00K | -106.89% |
Free cash flow | 4.60M | 216.40% |
About
Founded
2012
Headquarters
Website
Employees
32